SynthesisInternational journal of surgery (London, England)2026

Exploring the efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with homologous recombination repair alteration: a meta-analysis based on subgroups and reconstructed individual patient data.

Fuxun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.